SOMERSET, N.J., April 19, 2018 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, the leading global provider of advanced
The four workshops will each be presented multiple times throughout the conference, and will cover a broad range of current topics within the clinical supply industry focusing on:
"Catalent is proud to support the upcoming GCSG conference and help to advance many of the important topics facing the clinical supply industry," said Bernie Clark, Vice President of Marketing and BU Strategy. "Sharing our knowledge and encouraging innovative approaches and technologies is critical to meeting the demands our customers face in streamlining clinical trials and better serving patients every day."
For more information on these workshops or the GCSG Conference, visit catalent.com/GCSG. To arrange a meeting with attending Catalent executives at the event, contact Richard Kerns at NEPR – richard(at)nepr.eu.
About Catalent Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 11,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com
More products. Better treatments. Reliably supplied.™
SOURCE Catalent, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All